Heath Lukatch, Director at Vaxcyte, Inc. (PCVX), sold 335 shares at $44.01 ($15K) on 2022-12-12, disclosed to the SEC on 2022-12-14.
Scheduled sale ($15k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.37 | 16 | $678 | 4.6% |
| 2 | $44.01 | 319 | $14K | 95.4% |
| Total | $43.93 avg | 335 | $15K | 100% |
| Filing → |
| PCVX | SELL | 2024-01-04 | $1.6M | — | Filing → |
| PCVX | SELL | 2023-01-12 | $15K | — | Filing → |
| PCVX | SELL | 2022-11-15 | $200K | — | Filing → |